9/22/20 - Leaderboard - Pharma
 

Novasep

Rating: 0 - Write A Review
Site Eiffel, 82, bd de la Moselle
Pompey 54340
France
About Novasep
  • Novasep is a leading worldwide provider of integrated manufacturing solutions for the Life Science industries. We develop, market and operate innovative technologies from lab to industrial scale to produce biomolecules and synthetic molecules for the pharmaceutical, biopharmaceutical, agrochemical, fine chemical and industrial biotechnology markets.

    Our offering includes: process development services, custom synthesis and biomanufacturing (outsourcing solutions), purification processes, equipment and consumables (insourcing solutions), fine chemicals and generic active pharmaceutical ingredients.

    The company operates 12 R&D and manufacturing sites worldwide including six FDA inspected manufacturing plants. It employs approximately 1,200 people and had annual revenues of approx. EUR300 million in 2010.
Competitors of Novasep

  • Natoli Engineering Company, Inc.

    Natoli Engineering Company, long recognized as the global leader in tablet compression tooling manufacturing, was founded on the uncompromising principle to provide the highest quality tablet compression tooling, presses, and replacement parts at a fair price with exceptional customer service.... Read More

  • Aphena Pharma Solutions

    Aphena Pharma Solutions is a top-ranked service provider in the pharmaceutical, medical device and biologic industries. Aphena provides clients with a full range of pharmaceutical packaging and manufacturing services to advance their products to market --- complete, on time, on budget. With our... Read More

  • Southern Research

    Southern Research has established a reputation for providing high-quality drug discovery and development services to our research partners. With 6 FDA-approved therapies discovered at Southern Research and another 6 in late-stage preclinical development or clinical trials, we are continuously...
Pharma_MedRec_8.3.20
Pharma_3:1_01.18.18
Pharma_3:1_5.7.19
Pharma_3:1_1.11.19
Pharma 10/26/2018